Ballentine Partners LLC Sells 125 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Ballentine Partners LLC lessened its position in Mettler-Toledo International Inc. (NYSE:MTD) by 20.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 480 shares of the medical instruments supplier’s stock after selling 125 shares during the period. Ballentine Partners LLC’s holdings in Mettler-Toledo International were worth $587,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the company. Blue Trust Inc. grew its holdings in Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares during the period. Ashton Thomas Securities LLC bought a new position in shares of Mettler-Toledo International during the 3rd quarter worth approximately $37,000. Raleigh Capital Management Inc. increased its holdings in shares of Mettler-Toledo International by 272.7% during the 3rd quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after acquiring an additional 30 shares during the last quarter. Whittier Trust Co. of Nevada Inc. raised its stake in Mettler-Toledo International by 60.0% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock valued at $72,000 after acquiring an additional 18 shares during the period. Finally, Huntington National Bank lifted its holdings in Mettler-Toledo International by 20.0% during the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after purchasing an additional 9 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the sale, the director now owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Gerry Keller sold 140 shares of the company’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the transaction, the insider now owns 6 shares of the company’s stock, valued at $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Trading Up 0.8 %

Shares of Mettler-Toledo International stock opened at $1,335.76 on Friday. The company has a market cap of $28.19 billion, a PE ratio of 36.01, a price-to-earnings-growth ratio of 4.19 and a beta of 1.12. The company has a 50 day moving average of $1,245.04 and a 200-day moving average of $1,343.30. Mettler-Toledo International Inc. has a 1-year low of $1,133.46 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The firm had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. Research analysts forecast that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on MTD. Wolfe Research assumed coverage on shares of Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating on the stock. Stifel Nicolaus dropped their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Robert W. Baird decreased their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a report on Monday, November 11th. Wells Fargo & Company dropped their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Finally, Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and increased their target price for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.